Over the holidays, on the day after Christmas, Merck and Sanofi announced FDA approval of Vaxelis, a new hexavalent vaccine. It’s great news for children. Unsurprisingly, antivaxers hate it.
Over the holidays, on the day after Christmas, Merck and Sanofi announced FDA approval of Vaxelis, a new hexavalent vaccine. It’s great news for children. Unsurprisingly, antivaxers hate it.